首页> 外文期刊>Paediatrics and international child health >Advances in the management of primary monosymptomatic nocturnal enuresis in children
【24h】

Advances in the management of primary monosymptomatic nocturnal enuresis in children

机译:儿童原发性单症状性夜间遗尿症的治疗进展

获取原文
获取原文并翻译 | 示例
           

摘要

Intermittent incontinence of urine in a sleeping child who has previously been dry for less than 6 months without any other lower urinary tract symptoms is considered to be primary monosymptomatic nocturnal enuresis (PMNE). Although, most children outgrow PMNE with age, the psychological impact on the child warrants parental education and patient motivation and treatment. Motivational therapy, alarm therapy and drug therapy are the mainstay of treatment. Motivational and alarm therapy have better success rates than drug therapy alone. Desmopressin is the commonly used first-line drug and is best for short-term relief. Other drugs such as anticholinergics, imipramine and sertraline are used in resistant cases. This review focuses on the assessment and treatment of PMNE.
机译:先前已干燥不到6个月且无其他下尿路症状的睡眠儿童间歇性尿失禁被认为是原发性单症状性夜间遗尿症(PMNE)。尽管大多数孩子随着年龄的增长不再接受PMNE,但对孩子的心理影响值得父母教育以及患者的动机和治疗。动机疗法,警报疗法和药物疗法是治疗的主体。动机和警报疗法比单纯的药物疗法有更高的成功率。去氨加压素是常用的一线药物,最适合短期缓解。其他药物如抗胆碱能药,丙咪嗪和舍曲林用于耐药病例。这篇综述着重于PMNE的评估和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号